OTCMKTS:BCYP Big Cypress Acquisition (BCYP) Stock Forecast, Price & News $8.44 -2.01 (-19.23%) (As of 10/22/2021) Add Compare Share Share Today's Range$8.21▼$12.9050-Day Range$8.44▼$8.4452-Week Range$8.21▼$12.90Volume15.34 million shsAverage Volume160,982 shsMarket Capitalization$124.84 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsFinancialsInsider TradesInstitutional OwnershipHeadlinesProfileChartCompetitorsFinancialsInsider TradesInstitutional OwnershipHeadlines About Big Cypress Acquisition (OTCMKTS:BCYP) StockBig Cypress Acquisition Corp. does not have significant operations. The company intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or similar business combination. It primarily focuses in the life science sector. The company was incorporated in 2020 and is based in Miami Beach, Florida.Read More Receive BCYP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Big Cypress Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address BCYP Stock News HeadlinesApril 4, 2023 | forbes.comBig Ass FansApril 2, 2023 | americanbankingnews.comBig Cypress Acquisition (OTCMKTS:BCYP) Stock Price Passes Below Two Hundred Day Moving Average of $8.44June 2, 2023 | UNKNOWN (Ad)Lithium Has Boomed And This American Stock Is Ready..Lithium Has Been On A Crazy Rally Over The Last 3 Year's And This Stock Could Be Next!March 22, 2023 | americanbankingnews.comAnalyzing Relay Therapeutics (NASDAQ:RLAY) & Big Cypress Acquisition (OTCMKTS:BCYP)March 2, 2022 | reuters.comSAB Biotherapeutics IncOctober 21, 2021 | finance.yahoo.comBig Cypress Acquisition Corp. Stockholders Approve Business Combination with SAB BiotherapeuticsOctober 4, 2021 | finance.yahoo.comSAB Biotherapeutics Announces First Patient Dosed in Phase 3 NIH ACTIV-2 Trial Evaluating SAB-185 for Treatment of COVID-19September 28, 2021 | finance.yahoo.comSAB Biotherapeutics Appoints Russell Beyer Chief Financial OfficerJune 2, 2023 | Vantage Point (Ad)We Called (ARWR) In Advance, Which Stocks Are Next?Nearly 56% gains in 30 days! This bullish trend reversal was not only forecasted by A.I., but we called it 1 – 3 days in advance. If you have any money invested in the markets…even just your retirement, you’ll want to see this. Plus, it’s FREE - the training is only an hour & LIVE. September 24, 2021 | finance.yahoo.comSAB Biotherapeutics Announces SAB-185 Receives Positive DSMB Review and Advances to Phase 3 in NIH-Sponsored ACTIV-2 Trial for Treatment of COVID-19September 22, 2021 | finance.yahoo.comSAB Biotherapeutics Awarded Additional $60.5M from BARDA and U.S. Department of Defense for Rapid Response Capability and Advancing SAB-185 for Treatment of COVID-19September 15, 2021 | finance.yahoo.comSAB Biotherapeutics Announces Completion of Enrollment in Phase 2a Challenge Trial of SAB-176 for the Treatment of Seasonal InfluenzaSeptember 8, 2021 | finance.yahoo.comSAB Biotherapeutics to Present at Upcoming September Virtual Investor ConferencesAugust 11, 2021 | barrons.comBig Cypress Acquisition Corp.August 11, 2021 | finance.yahoo.comSAB Biotherapeutics Announces Nonclinical Data Demonstrating SAB-185 Potently Neutralizes Delta and Lambda SARS-CoV-2 VariantsAugust 10, 2021 | nasdaq.comBig Cypress Acquisition Corp. Common stock (BCYP)July 15, 2021 | in.finance.yahoo.comSTMP Jul 2021 300.000 putJuly 15, 2021 | finance.yahoo.comBig Cypress Acquisition Corp. Reports Ladenburg Conference Presentation by Planned Merger Partner SAB BiotherapeuticsJuly 10, 2021 | finance.yahoo.comLifshitz Law Firm, P.C. Announces Investigation of ALTA, BCYP, IKNX and STMPJuly 7, 2021 | finance.yahoo.comBig Cypress Acquisition Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination with SAB BiotherapeuticsJune 28, 2021 | finance.yahoo.comNOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith Reminds Investors of Investigations Related to the Following Companies: CITIC Capital Acquisition Corp. (NYSE - CCAC), Thimble Point Acquisition Corp. (Nasdaq - THMA), Big Cypress Acquisition Corp. (Nasdaq - BCYP)June 25, 2021 | apnews.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Big Cypress Acquisition Corp.June 25, 2021 | feeds.benzinga.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Big Cypress Acquisition Corp. MergerJune 22, 2021 | finance.yahoo.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Big Cypress Acquisition Corp. (Nasdaq - BCYP)June 22, 2021 | finance.yahoo.comSAB Biotherapeutics to List on Nasdaq through Merger with Big Cypress Acquisition Corp., Advancing Unique Human Antibody Platform with Demonstrated Utility in Immunotherapy and Rapid Response to Emerging DiseasesJune 11, 2021 | investing.comBig Cypress Acquisition Corp (BCYP)April 26, 2021 | msn.comInside Primary Wave’s $1.5 Billion Hit FactorySee More Headlines BCYP Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BCYP Company Calendar Last Earnings11/11/2014Today6/01/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Biological Products, Except Diagnostic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:BCYP CUSIPN/A CIK1399587 Webwww.bluecalypso.com Phone305-204-3338FaxN/AEmployees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio6.13 Quick Ratio6.13 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares14,792,000Free FloatN/AMarket Cap$124.84 million OptionableNot Optionable BetaN/A Key ExecutivesMr. Samuel J. Reich (Age 46)CEO, CFO & Director Key CompetitorsaTyr PharmaNASDAQ:LIFESolid BiosciencesNASDAQ:SLDBProtalix BioTherapeuticsNYSEAMERICAN:PLXCidara TherapeuticsNASDAQ:CDTXBrainstorm Cell TherapeuticsNASDAQ:BCLIView All Competitors BCYP Stock - Frequently Asked Questions How have BCYP shares performed in 2023? Big Cypress Acquisition's stock was trading at $8.44 at the start of the year. Since then, BCYP shares have increased by 0.0% and is now trading at $8.44. View the best growth stocks for 2023 here. How were Big Cypress Acquisition's earnings last quarter? Big Cypress Acquisition Corp. (OTCMKTS:BCYP) announced its quarterly earnings data on Tuesday, November, 11th. The technology company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01). The technology company had revenue of $0.31 million for the quarter, compared to analyst estimates of $0.21 million. What other stocks do shareholders of Big Cypress Acquisition own? Based on aggregate information from My MarketBeat watchlists, some companies that other Big Cypress Acquisition investors own include Co-Diagnostics (CODX), iBio (IBIO), PharmaCyte Biotech (PMCB), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Ascent Solar Technologies (ASTI), BioRestorative Therapies (BRTX), Digital Ally (DGLY) and FuelCell Energy (FCEL). What is Big Cypress Acquisition's stock symbol? Big Cypress Acquisition trades on the OTCMKTS under the ticker symbol "BCYP." How do I buy shares of Big Cypress Acquisition? Shares of BCYP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Big Cypress Acquisition's stock price today? One share of BCYP stock can currently be purchased for approximately $8.44. How much money does Big Cypress Acquisition make? Big Cypress Acquisition (OTCMKTS:BCYP) has a market capitalization of $124.84 million. How can I contact Big Cypress Acquisition? Big Cypress Acquisition's mailing address is 101 W. RENNER RD., RICHARDSON TX, 75082. The official website for the company is www.bluecalypso.com. The technology company can be reached via phone at 305-204-3338 or via email at investors@bluecalypso.com. This page (OTCMKTS:BCYP) was last updated on 6/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Big Cypress Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.